Pharmacogenomic testing for psychotropic medication selection: a systematic review of the Assurex GeneSight Psychotropic test
Health Quality Ontario
Record ID 32017000240
English
Authors' recommendations:
There is uncertainty about the use of GeneSight Psychotropic pharmacogenomic genetic panel
to guide medication selection. It was associated with improvements in some patient outcomes,
but not others. As well, our confidence in these findings is low because of limitations in the body
of evidence.
Details
Project Status:
Completed
Year Published:
2017
URL for published report:
http://www.hqontario.ca/Portals/0/documents/evidence/reports/hta-genesight-13-03-2017-en.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Pharmacogenetics
- Pharmacogenomic Testing
- Psychotropic Drugs
Contact
Organisation Name:
Health Quality Ontario
Contact Address:
Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5
Contact Name:
EDSinfo@hqontario.ca
Contact Email:
OH-HQO_hta-reg@ontariohealth.ca
Copyright:
Health Quality Ontario (HQO)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.